PfEMP1 as a target of human immunity and a vaccine candidate against malaria

Expert Review of Vaccines

Volumn 12, Issue 2, 2013, Pages 105-108

  Beeson, James G ^a   Chan, Jo Anne ^a   Fowkes, Freya J I ^a  

^a BURNET INSTITUTE   (Australia)

Author keywords

antibodies; malaria; PfEMP1; Plasmodium falciparum; vaccine; variant surface antigens

Indexed keywords

EPITOPE; ERYTHROCYTE MEMBRANE PROTEIN 1; MALARIA VACCINE; PARASITE ANTIBODY;

ANTIGENIC VARIATION; COMPLEMENT FIXATION; CROSS REACTION; DRUG EFFICACY; DRUG TARGETING; ENDEMIC DISEASE; ERYTHROCYTE; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOPATHOGENESIS; LIFE CYCLE; MALARIA; MALARIA FALCIPARUM; MEROZOITE; NONHUMAN; PARASITE IMMUNITY; PARASITE VIRULENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW;

ANTIBODIES, PROTOZOAN; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; BIOMEDICAL RESEARCH; HUMANS; MALARIA; MALARIA VACCINES; PROTOZOAN PROTEINS;

EID: 84874064187     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.144     Document Type: Review

References (20)

1. Richards JS, Beeson JG. The future for blood-stage vaccines against malaria. Immunol. Cell Biol. 87(5), 377-390 (2009).
2. Beeson JG, Brown GV. Pathogenesis of Plasmodium falciparum malaria: the roles of parasite adhesion and antigenic variation. Cell. Mol. Life Sci. 59(2), 258-271 (2002).
3. Leech JH, Barnwell JW, Miller LH, Howard RJ. Identification of a strainspecific malarial antigen exposed on the surface of Plasmodium falciparuminfected erythrocytes. J. Exp. Med. 159(6), 1567-1575 (1984).
4. Marsh K, Howard RJ. Antigens induced on erythrocytes by P. falciparum: expression of diverse and conserved determinants. Science 231(4734), 150-153 (1986).
5. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat. Med. 4(3), 358-360 (1998).
6. Smith JD, Chitnis CE, Craig AG et al. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82(1), 101-110 (1995).
7. Mackintosh CL, Christodoulou Z, Mwangi TW et al. Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. Malar. J. 7, 155 (2008).
8. Magistrado PA, Lusingu J, Vestergaard LS et al. Immunoglobulin G antibody reactivity to a group A Plasmodium falciparum erythrocyte membrane protein 1 and protection from P. falciparum malaria. Infect. Immun. 75(5), 2415-2420 (2007).
9. Chan JA, Howell KB, Reiling L et al. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J. Clin. Invest. 122(9), 3227-3238 (2012).
10. Udeinya IJ, Miller LH, McGregor IA, Jensen JB. Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature 303(5916), 429-431 (1983).
11. Celada A, Cruchaud A, Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin. Exp. Immunol. 47(3), 635-644 (1982).
12. Fowkes FJ, McGready R, Cross NJ et al. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women. J. Infect. Dis. 206(10), 1612-1621 (2012).
13. Baruch DI, Gamain B, Barnwell JW et al. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc. Natl Acad. Sci. USA 99(6), 3860-3865 (2002).
14. Gratepanche S, Gamain B, Smith JD, Robinson BA, Saul A, Miller LH. Induction of crossreactive antibodies against the Plasmodium falciparum variant protein. Proc. Natl Acad. Sci. USA 100(22), 13007-13012 (2003).
15. Ahuja S, Pettersson F, Moll K, Jonsson C, Wahlgren M, Chen Q. Induction of cross-reactive immune responses to NTSDBL-1?/x of PfEMP1 and in vivo protection on challenge with Plasmodium falciparum. Vaccine 24(35-36), 6140-6154 (2006).
16. Ghumra A, Khunrae P, Ataide R et al. Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. PLoS ONE 6(1), e16414 (2011).
17. Salanti A, Dahlbäck M, Turner L et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200(9), 1197-1203 (2004).
18. Hommel M, Elliott SR, Soma V et al. Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women. Infect. Immun. 78(5), 1963-1978 (2010).
19. Drew DR, Hodder AN, Wilson DW et al. Defining the antigenic diversity of Plasmodium falciparum apical membrane protein 1 and the requirements for a multiallele vaccine against malaria. PLoS One doi:10.1371/journal.pone.0051023 (2012).
20. Avril M, Tripathi AK, Brazier AJ et al. A restricted subset of var genes mediates adherence of Plasmodium falciparuminfected erythrocytes to brain endothelial cells. Proc. Natl Acad. Sci. USA 109(26), E1782-E1790 (2012).